Connect with us

Hi, what are you looking for?

Wednesday, May 13, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "COMP360"

Compass Pathways scores FDA priority voucher for synthetic psilocybin drug

Compass Pathways scores FDA priority voucher for synthetic psilocybin drug

Psychedelics

Compass Pathways scores FDA priority voucher for synthetic psilocybin drug

Three companies were awarded the vouchers after Trump's executive order was signed

Rowan DunneApril 30, 2026

AI shows potential for predicting psilocybin therapy outcomes COMPASS study

AI shows potential for predicting psilocybin therapy outcomes COMPASS study

Psychedelics

AI shows potential for predicting psilocybin therapy outcomes: COMPASS study

The paper in the journal Psychopharmacology concluded that a machine learning algorithm could predict treatment efficacy

Rowan DunneSeptember 8, 2023

More Posts